Latest Insider Transactions at Synthetic Biologics, Inc. (SYN)
This section provides a real-time view of insider transactions for Synthetic Biologics, Inc. (SYN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Synthetic Biologics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Synthetic Biologics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2023
|
Shallcross Steven A CEO and CFO |
BUY
Open market or private purchase
|
Direct |
14,000
+5.3%
|
$0
$0.69 P/Share
|
|
Jun 06
2023
|
Shallcross Steven A CEO and CFO |
BUY
Open market or private purchase
|
Direct |
26,000
+9.92%
|
$0
$0.63 P/Share
|
|
Feb 10
2023
|
Shallcross Steven A CEO and CFO |
BUY
Open market or private purchase
|
Direct |
25,000
+10.64%
|
$25,000
$1.04 P/Share
|
|
Feb 02
2023
|
Shallcross Steven A CEO and CFO |
BUY
Open market or private purchase
|
Direct |
25,000
+11.9%
|
$0
$0.94 P/Share
|
|
Jan 25
2023
|
Shallcross Steven A CEO and CFO |
BUY
Open market or private purchase
|
Direct |
25,000
+13.51%
|
$0
$0.87 P/Share
|
|
Jan 20
2023
|
Shallcross Steven A CEO and CFO |
BUY
Open market or private purchase
|
Direct |
25,000
+15.63%
|
$0
$0.75 P/Share
|
|
Dec 29
2022
|
Shallcross Steven A CEO and CFO |
BUY
Open market or private purchase
|
Direct |
100,000
+47.62%
|
$0
$0.44 P/Share
|
|
May 10
2021
|
Shallcross Steven A CEO and CFO |
BUY
Open market or private purchase
|
Direct |
50,000
+33.33%
|
$0
$0.49 P/Share
|